Global Antibody Drug Conjugates (ADCs) Market Growth (Status and Outlook) 2022-2028
- LP 4809198
- 101 Pages
- February 2022
- Pharmaceuticals
The United States Antibody Drug Conjugates (ADCs) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibody Drug Conjugates (ADCs) market, reaching US$ million by the year 2028. As for the Europe Antibody Drug Conjugates (ADCs) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibody Drug Conjugates (ADCs) players cover Roche, Pfizer, Novartis, and Genmab, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugates (ADCs) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Seattle Genetics Technology
ImmunoGen Technology
Immunomedics Technology
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Pfizer
Novartis
Genmab
Bayer
Seattle Genetics
Takeda Pharmaceuticals
AbbVie
AbGenomics
ADC Therapeutics
Astellas Pharma
Kairos Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugates (ADCs) Market Size 2017-2028
2.1.2 Antibody Drug Conjugates (ADCs) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antibody Drug Conjugates (ADCs) Segment by Type
2.2.1 Seattle Genetics Technology
2.2.2 ImmunoGen Technology
2.2.3 Immunomedics Technology
2.3 Antibody Drug Conjugates (ADCs) Market Size by Type
2.3.1 Antibody Drug Conjugates (ADCs) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Type (2017-2022)
2.4 Antibody Drug Conjugates (ADCs) Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Others
2.5 Antibody Drug Conjugates (ADCs) Market Size by Application
2.5.1 Antibody Drug Conjugates (ADCs) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Application (2017-2022)
3 Antibody Drug Conjugates (ADCs) Market Size by Player
3.1 Antibody Drug Conjugates (ADCs) Market Size Market Share by Players
3.1.1 Global Antibody Drug Conjugates (ADCs) Revenue by Players (2020-2022)
3.1.2 Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Players (2020-2022)
3.2 Global Antibody Drug Conjugates (ADCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Drug Conjugates (ADCs) by Regions
4.1 Antibody Drug Conjugates (ADCs) Market Size by Regions (2017-2022)
4.2 Americas Antibody Drug Conjugates (ADCs) Market Size Growth (2017-2022)
4.3 APAC Antibody Drug Conjugates (ADCs) Market Size Growth (2017-2022)
4.4 Europe Antibody Drug Conjugates (ADCs) Market Size Growth (2017-2022)
4.5 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antibody Drug Conjugates (ADCs) Market Size by Country (2017-2022)
5.2 Americas Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022)
5.3 Americas Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugates (ADCs) Market Size by Region (2017-2022)
6.2 APAC Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022)
6.3 APAC Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Drug Conjugates (ADCs) by Country (2017-2022)
7.2 Europe Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022)
7.3 Europe Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Drug Conjugates (ADCs) by Region (2017-2022)
8.2 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022)
8.3 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibody Drug Conjugates (ADCs) Market Forecast
10.1 Global Antibody Drug Conjugates (ADCs) Forecast by Regions (2023-2028)
10.1.1 Global Antibody Drug Conjugates (ADCs) Forecast by Regions (2023-2028)
10.1.2 Americas Antibody Drug Conjugates (ADCs) Forecast
10.1.3 APAC Antibody Drug Conjugates (ADCs) Forecast
10.1.4 Europe Antibody Drug Conjugates (ADCs) Forecast
10.1.5 Middle East & Africa Antibody Drug Conjugates (ADCs) Forecast
10.2 Americas Antibody Drug Conjugates (ADCs) Forecast by Country (2023-2028)
10.2.1 United States Antibody Drug Conjugates (ADCs) Market Forecast
10.2.2 Canada Antibody Drug Conjugates (ADCs) Market Forecast
10.2.3 Mexico Antibody Drug Conjugates (ADCs) Market Forecast
10.2.4 Brazil Antibody Drug Conjugates (ADCs) Market Forecast
10.3 APAC Antibody Drug Conjugates (ADCs) Forecast by Region (2023-2028)
10.3.1 China Antibody Drug Conjugates (ADCs) Market Forecast
10.3.2 Japan Antibody Drug Conjugates (ADCs) Market Forecast
10.3.3 Korea Antibody Drug Conjugates (ADCs) Market Forecast
10.3.4 Southeast Asia Antibody Drug Conjugates (ADCs) Market Forecast
10.3.5 India Antibody Drug Conjugates (ADCs) Market Forecast
10.3.6 Australia Antibody Drug Conjugates (ADCs) Market Forecast
10.4 Europe Antibody Drug Conjugates (ADCs) Forecast by Country (2023-2028)
10.4.1 Germany Antibody Drug Conjugates (ADCs) Market Forecast
10.4.2 France Antibody Drug Conjugates (ADCs) Market Forecast
10.4.3 UK Antibody Drug Conjugates (ADCs) Market Forecast
10.4.4 Italy Antibody Drug Conjugates (ADCs) Market Forecast
10.4.5 Russia Antibody Drug Conjugates (ADCs) Market Forecast
10.5 Middle East & Africa Antibody Drug Conjugates (ADCs) Forecast by Region (2023-2028)
10.5.1 Egypt Antibody Drug Conjugates (ADCs) Market Forecast
10.5.2 South Africa Antibody Drug Conjugates (ADCs) Market Forecast
10.5.3 Israel Antibody Drug Conjugates (ADCs) Market Forecast
10.5.4 Turkey Antibody Drug Conjugates (ADCs) Market Forecast
10.5.5 GCC Countries Antibody Drug Conjugates (ADCs) Market Forecast
10.6 Global Antibody Drug Conjugates (ADCs) Forecast by Type (2023-2028)
10.7 Global Antibody Drug Conjugates (ADCs) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Antibody Drug Conjugates (ADCs) Product Offered
11.1.3 Roche Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Antibody Drug Conjugates (ADCs) Product Offered
11.2.3 Pfizer Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Antibody Drug Conjugates (ADCs) Product Offered
11.3.3 Novartis Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Genmab
11.4.1 Genmab Company Information
11.4.2 Genmab Antibody Drug Conjugates (ADCs) Product Offered
11.4.3 Genmab Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Genmab Main Business Overview
11.4.5 Genmab Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Antibody Drug Conjugates (ADCs) Product Offered
11.5.3 Bayer Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Seattle Genetics
11.6.1 Seattle Genetics Company Information
11.6.2 Seattle Genetics Antibody Drug Conjugates (ADCs) Product Offered
11.6.3 Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Seattle Genetics Main Business Overview
11.6.5 Seattle Genetics Latest Developments
11.7 Takeda Pharmaceuticals
11.7.1 Takeda Pharmaceuticals Company Information
11.7.2 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product Offered
11.7.3 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Takeda Pharmaceuticals Main Business Overview
11.7.5 Takeda Pharmaceuticals Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Antibody Drug Conjugates (ADCs) Product Offered
11.8.3 AbbVie Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 AbGenomics
11.9.1 AbGenomics Company Information
11.9.2 AbGenomics Antibody Drug Conjugates (ADCs) Product Offered
11.9.3 AbGenomics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 AbGenomics Main Business Overview
11.9.5 AbGenomics Latest Developments
11.10 ADC Therapeutics
11.10.1 ADC Therapeutics Company Information
11.10.2 ADC Therapeutics Antibody Drug Conjugates (ADCs) Product Offered
11.10.3 ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 ADC Therapeutics Main Business Overview
11.10.5 ADC Therapeutics Latest Developments
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Information
11.11.2 Astellas Pharma Antibody Drug Conjugates (ADCs) Product Offered
11.11.3 Astellas Pharma Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Astellas Pharma Main Business Overview
11.11.5 Astellas Pharma Latest Developments
11.12 Kairos Therapeutics
11.12.1 Kairos Therapeutics Company Information
11.12.2 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product Offered
11.12.3 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Kairos Therapeutics Main Business Overview
11.12.5 Kairos Therapeutics Latest Developments
12 Research Findings and Conclusion
Table 1. Antibody Drug Conjugates (ADCs) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Seattle Genetics Technology
Table 3. Major Players of ImmunoGen Technology
Table 4. Major Players of Immunomedics Technology
Table 5. Antibody Drug Conjugates (ADCs) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Type (2017-2022)
Table 8. Antibody Drug Conjugates (ADCs) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Application (2017-2022)
Table 11. Global Antibody Drug Conjugates (ADCs) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Player (2020-2022)
Table 13. Antibody Drug Conjugates (ADCs) Key Players Head office and Products Offered
Table 14. Antibody Drug Conjugates (ADCs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antibody Drug Conjugates (ADCs) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Antibody Drug Conjugates (ADCs) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Antibody Drug Conjugates (ADCs) Market Size Market Share by Country (2017-2022)
Table 21. Americas Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Antibody Drug Conjugates (ADCs) Market Size Market Share by Type (2017-2022)
Table 23. Americas Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Antibody Drug Conjugates (ADCs) Market Size Market Share by Application (2017-2022)
Table 25. APAC Antibody Drug Conjugates (ADCs) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Antibody Drug Conjugates (ADCs) Market Size Market Share by Region (2017-2022)
Table 27. APAC Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Antibody Drug Conjugates (ADCs) Market Size Market Share by Type (2017-2022)
Table 29. APAC Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Antibody Drug Conjugates (ADCs) Market Size Market Share by Application (2017-2022)
Table 31. Europe Antibody Drug Conjugates (ADCs) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Antibody Drug Conjugates (ADCs) Market Size Market Share by Country (2017-2022)
Table 33. Europe Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Antibody Drug Conjugates (ADCs) Market Size Market Share by Type (2017-2022)
Table 35. Europe Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Antibody Drug Conjugates (ADCs) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugates (ADCs)
Table 44. Key Market Challenges & Risks of Antibody Drug Conjugates (ADCs)
Table 45. Key Industry Trends of Antibody Drug Conjugates (ADCs)
Table 46. Global Antibody Drug Conjugates (ADCs) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Antibody Drug Conjugates (ADCs) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Antibody Drug Conjugates (ADCs) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Antibody Drug Conjugates (ADCs) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Antibody Drug Conjugates (ADCs) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Antibody Drug Conjugates (ADCs) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Roche Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 53. Roche Antibody Drug Conjugates (ADCs) Product Offered
Table 54. Roche Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Pfizer Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 58. Pfizer Antibody Drug Conjugates (ADCs) Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Pfizer Latest Developments
Table 62. Novartis Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 63. Novartis Antibody Drug Conjugates (ADCs) Product Offered
Table 64. Novartis Main Business
Table 65. Novartis Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Novartis Latest Developments
Table 67. Genmab Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 68. Genmab Antibody Drug Conjugates (ADCs) Product Offered
Table 69. Genmab Main Business
Table 70. Genmab Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Genmab Latest Developments
Table 72. Bayer Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 73. Bayer Antibody Drug Conjugates (ADCs) Product Offered
Table 74. Bayer Main Business
Table 75. Bayer Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Bayer Latest Developments
Table 77. Seattle Genetics Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 78. Seattle Genetics Antibody Drug Conjugates (ADCs) Product Offered
Table 79. Seattle Genetics Main Business
Table 80. Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Seattle Genetics Latest Developments
Table 82. Takeda Pharmaceuticals Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 83. Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product Offered
Table 84. Takeda Pharmaceuticals Main Business
Table 85. Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Takeda Pharmaceuticals Latest Developments
Table 87. AbbVie Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 88. AbbVie Antibody Drug Conjugates (ADCs) Product Offered
Table 89. AbbVie Main Business
Table 90. AbbVie Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. AbbVie Latest Developments
Table 92. AbGenomics Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 93. AbGenomics Antibody Drug Conjugates (ADCs) Product Offered
Table 94. AbGenomics Main Business
Table 95. AbGenomics Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. AbGenomics Latest Developments
Table 97. ADC Therapeutics Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 98. ADC Therapeutics Antibody Drug Conjugates (ADCs) Product Offered
Table 99. ADC Therapeutics Main Business
Table 100. ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. ADC Therapeutics Latest Developments
Table 102. Astellas Pharma Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 103. Astellas Pharma Antibody Drug Conjugates (ADCs) Product Offered
Table 104. Astellas Pharma Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Astellas Pharma Main Business
Table 106. Astellas Pharma Latest Developments
Table 107. Kairos Therapeutics Details, Company Type, Antibody Drug Conjugates (ADCs) Area Served and Its Competitors
Table 108. Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product Offered
Table 109. Kairos Therapeutics Main Business
Table 110. Kairos Therapeutics Antibody Drug Conjugates (ADCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Kairos Therapeutics Latest Developments
List of Figures
Figure 1. Antibody Drug Conjugates (ADCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Drug Conjugates (ADCs) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Type in 2021
Figure 7. Antibody Drug Conjugates (ADCs) in Hospital
Figure 8. Global Antibody Drug Conjugates (ADCs) Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Antibody Drug Conjugates (ADCs) in Clinics
Figure 10. Global Antibody Drug Conjugates (ADCs) Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Antibody Drug Conjugates (ADCs) in Others
Figure 12. Global Antibody Drug Conjugates (ADCs) Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Application in 2021
Figure 14. Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Player in 2021
Figure 15. Global Antibody Drug Conjugates (ADCs) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Antibody Drug Conjugates (ADCs) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Antibody Drug Conjugates (ADCs) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Antibody Drug Conjugates (ADCs) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Antibody Drug Conjugates (ADCs) Value Market Share by Country in 2021
Figure 21. Americas Antibody Drug Conjugates (ADCs) Consumption Market Share by Type in 2021
Figure 22. Americas Antibody Drug Conjugates (ADCs) Market Size Market Share by Application in 2021
Figure 23. United States Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Antibody Drug Conjugates (ADCs) Market Size Market Share by Region in 2021
Figure 28. APAC Antibody Drug Conjugates (ADCs) Market Size Market Share by Application in 2021
Figure 29. China Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Antibody Drug Conjugates (ADCs) Market Size Market Share by Country in 2021
Figure 36. Europe Antibody Drug Conjugates (ADCs) Market Size Market Share by Type in 2021
Figure 37. Europe Antibody Drug Conjugates (ADCs) Market Size Market Share by Application in 2021
Figure 38. Germany Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size Market Share by Application in 2021
Figure 46. Egypt Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Antibody Drug Conjugates (ADCs) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 55. United States Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 59. China Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 63. India Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 66. France Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 67. UK Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Antibody Drug Conjugates (ADCs) Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
